In specimens with melanoma tumors, NK cells (CD16 + CD56+) and iNKT cells (CD1D + TCRvB8.1) from peripheral blood are active (CD107a+) and preserve immature markers, such as Sca-1+, in addition to the transcription factor/immaturity c-kit (CD117+). This evidence concerns the gene CD1D and melanoma.